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Epilepsies comprise a family of multifactorial neurological disorders that affect at least 50
million people worldwide. Despite a long history of neurobiological and clinical studies
the mechanisms that lead the brain network to a hyperexcitable state and to the intense,
massive neuronal discharges reflecting a seizure episode are only partially defined. Most
epilepsies of genetic origin are related to mutations in ionic channels that cause neuronal
hyperexcitability. However, idiopathic epilepsies of unclear origin represent the majority
of these brain disorders. A large body of evidence suggests that in the epileptic brain
neurons are not the only players. Indeed, the glial cell astrocyte is known to be morpholog-
ically and functionally altered in different types of epilepsy. Although it is unclear whether
these astrocyte dysfunctions can have a causative role in epileptogenesis, the hypothesis
that astrocytes contribute to epileptiform activities recently received a considerable experi-
mental support. Notably, currently used antiepileptic drugs, that act mainly on neuronal ion
channels, are ineffective in a large group of patients. Clarifying astrocyte functions in the
epileptic brain tissue could unveil astrocytes as novel therapeutic targets. In this review we
present first a short overview on the role of astrocytes in the epileptic brain starting from
the “historical” observations on their fundamental modulation of brain homeostasis, such
as the control of water content, ionic equilibrium, and neurotransmitters concentrations.
We then focus our review on most recent studies that hint at a distinct contribution of
these cells in the generation of focal epileptiform activities.
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INTRODUCTION
Epilepsies are caused by genetic or acquired factors, such as brain
injury, post-infection lesions, and tumors and affect at least 50 mil-
lion people worldwide (Ngugi et al., 2010; Thurman et al., 2011).
An epileptic seizure is the clinical manifestation of an abnor-
mal and excessive discharge that initially involves neurons from
a restricted brain site (the epileptogenic focus) and then propa-
gates to nearby neuronal populations eventually spreading to the
entire brain. Most currently used antiepileptic drugs (AEDs) tar-
get either voltage-sensitive ion channels or GABAergic signaling
reducing neuronal excitability or increasing inhibition in the brain
network, respectively (Rogawski and Loscher, 2004). These drugs
are, however, ineffective in a large portion of epileptic patients and
their anticonvulsant action is often accompanied by relevant side
effects. Novel therapeutic targets are, therefore, highly demanded.
A different relatively unexploited strategy would be to target
the glia cell astrocytes. These cells are key players in the control of
the brain tissue homeostasis by regulating water content and K+
extracellular levels and by providing neurons with nutrients and
trophic factors. Astrocytes play a prominent role in neurovascu-
lar coupling mechanism (Zonta et al., 2003; Takano et al., 2006;
for recent reviews, see Carmignoto and Gomez-Gonzalo, 2010;
Petzold and Murthy, 2011) and are also largely responsible for
maintaining physiological levels of glutamate (Rothstein et al.,
1994, 1996; Huang et al., 2004) and GABA in the extracellular
space (Conti et al., 2004; Madsen et al., 2010). In addition, astro-
cytes participate with microglial cells in the defensive response
against endo and exogenous insults by releasing various cytokines
and pro-inflammatory mediators that ultimately have a procon-
vulsant action (Turrin and Rivest,2004;Vezzani and Granata,2005;
Vezzani et al., 2008; Fabene et al., 2010).
While the astrocytic contribution to these processes is well
recognized since many decades, more recent works have greatly
extended the role of astrocytes from the control of brain tissue
homeostasis to the modulation of synaptic transmission and net-
work activities. At the start of the nineties a number of pioneering
studies showed that glutamate applications in cell cultures and
brain slice preparations evoked Ca2+ elevations and propagating
Ca2+ waves in astrocytes (Dani et al., 1992). Subsequent observa-
tions revealed that Ca2+ elevations in astrocytes triggered gluta-
mate release that evoked AMPA and NMDA receptor-mediated
Ca2+ increases in nearby neurons (Nedergaard, 1994; Parpura
et al., 1994; Pasti et al., 1997). The indication of an astrocyte-to-
neuron signaling represented a turning point in astrocyte research
and paved the way to studies in brain slice preparations and
in vivo which essentially confirmed the existence of a complex
bidirectional signaling between neurons and astrocytes (Zonta
and Carmignoto, 2002). We now know that astrocytes express a
large variety of receptors that can be activated by various neuro-
transmitters, such as glutamate (Porter and McCarthy, 1996; Pasti
et al., 1997), GABA (Kang et al., 1998), noradrenaline (Duffy and
MacVicar, 1995; Kulik et al., 1999), acetylcholine (Shelton and
McCarthy, 2000; Araque et al., 2002), ATP, and also by cannabi-
noids released by neuronal dendrites (Navarrete and Araque, 2008,
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2010). These molecules evoke Ca2+ elevations in astrocytes that,
in turn, release other transmitters including glutamate, d-serine,
and ATP. By means of these transmitters, termed gliotransmit-
ters, astrocytes affect neuronal excitability, and modulate synaptic
transmission. Beside these gliotransmitters astrocytes can release
cytokines such as IL-1β and TNFα, as well as other molecules such
as TGFβ, GDNF, BDNF, nitric oxide, and neurosteroids that can
also affect neuronal functions. The ability of astrocytes to listen
and talk to synapses by exerting both excitatory and inhibitory
actions on neurons (Pasti et al., 1997; Araque et al., 1999; Brock-
haus and Deitmer, 2002; Zhang et al., 2003; Pascual et al., 2005;
Panatier et al., 2006, 2011; Serrano et al., 2006; Jourdain et al., 2007;
Perea and Araque, 2007; Di Castro et al., 2011; Shigetomi et al.,
2011; Min and Nevian, 2012; Navarrete et al., 2012) is revolution-
izing our original view that information processing in the brain is
exclusively based on billions of neurons interacting dynamically in
the neuronal network. On the other hand, clues for a distinct con-
tribution of astrocytes in the highest functions of the mammalian
brain during phylogeny are the increasing complexity and size of
protoplasmic astrocytes with respect to the unchanged features
of cortical neurons, and the relative expansion in the number of
astrocytes with respect to that of neurons (Oberheim et al., 2006,
2009). All in all, the astrocyte is now proposed to represent an
intrinsic element of the neuronal circuit that composes a tripartite
synapse with the pre- and the post-synaptic neuronal membrane
(Araque et al., 1999; Carmignoto, 2000; Haydon and Carmignoto,
2006; Halassa et al., 2009; Perea et al., 2009).
The discovery that astrocytes modulate neuronal communi-
cation and are involved in the control of brain network activi-
ties suggest that astrocytes have the potential to be involved in
the development of a number of brain disorders, from acute
brain injury or infection to chronic diseases including Alzheimer’s
diseases, Parkinson disease, amyotrophic lateral sclerosis, and
epilepsy (Maragakis and Rothstein, 2006; Seifert et al., 2006; Black-
burn et al., 2009). The aforementioned observations on Ca2+-
dependent release of glutamate in astrocytes providing direct
excitation to neighboring neurons is of particular interest in
the context of epileptogenesis. Accordingly, alterations in this
astrocyte-derived excitatory pathway in concert with impaired
astrocytic glutamate and K+ uptake may result in a hyperexcitable
neuron-astrocyte network which favors neuronal synchronization
and ultimately predisposes neurons to seizures. In this review we
present an overview of the “historical” observations that suggested
a role of astrocytes in the epileptic brain and we also critically dis-
cuss the most recent results that hint at a distinct contribution of
astrocytes in the generation of focal epileptiform activities.
ASTROCYTES IN THE EPILEPTIC BRAIN
It has been known for a long time that early in the development of
many brain disorders, astrocytes exhibit significant morphologi-
cal and functional changes (Hamby and Sofroniew, 2010). This
condition, termed reactive gliosis, comprises increased number,
altered morphology with hypertrophic soma and processes, spatial
overlapping and different functional changes of astrocytes. Gliosis
is frequent in the human epileptic brain and seizures have been
shown to frequently initiate within or very near gliotic brain tissues
(McKhann et al., 2000). Gliosis is frequently observed in temporal
lobe epilepsies (TLE), a severe form of partial epilepsy with focal
onset in temporal structures such as hippocampus, entorhinal cor-
tex, and amygdala. Surgical ablation of the epileptogenic region
may be the only treatment available in the most severe forms of
TLE that are resistant to all the currently available AEDs. Studies
from these tissues, as well as from post-mortem tissues or from
animal models, have shown relevant alterations of neuronal and
astrocytic morphology. It is important to point out that it is still
unclear whether an altered glial morphology can contribute to the
generation of the disorder or be a consequence of an established
damage of the brain tissue. This especially holds for human tissues
from patients that may be suffering from the pathology since many
years, rather than for animal models in which investigations can
be more easily performed at different steps of the disease.
The most frequent and striking alteration in TLE is hippocam-
pal sclerosis which is characterized by a massive gliosis, neuronal
loss, synaptic, and microvascular reorganization. Gliosis, that can
be revealed by increased expression of glial fibrillary acidic pro-
tein (GFAP, an intermediate filament protein), has been described
also in other forms of epilepsies like post-traumatic and infection-
induced epilepsy (Seifert et al., 2006). In animal models, including
the pilocarpine- and the kainate-induced epilepsy, gliosis is also
early observed during the period that precedes recurrent seizure
onset, suggesting a causative role of astrocytes in epileptogenesis
(Represa et al., 1995; Belluardo et al., 1996; Bouilleret et al., 1999;
Borges et al., 2003; Rizzi et al., 2003).
While we have only a limited knowledge of the functional
changes occurring in reactive astrocytes, we can reasonably
advance the hypothesis that an astrocyte dysfunction contributes
or even plays a central role in epileptogenesis. Notably, although
astrocyte abnormalities have been, in general, linked to procon-
vulsant actions, astrocyte signals can also exert an anticonvulsants
action in a context-dependent manner. In the following sections
we will examine to what extent an impairment of a distinct
astrocytic function may contribute to modulate brain network
excitability ultimately favoring, or opposing, the generation and
spread of seizure-like discharges. In view of the recognized role
played by gliotransmission in various forms of synaptic plasticity
(Serrano et al., 2006; Florian et al., 2011; Panatier et al., 2011; Min
and Nevian, 2012; Navarrete et al., 2012), it is worth underlying
that the cognitive deficits observed in a number of neurologi-
cal disorders, including epilepsy, may be due, at least in part, to
an impairment of the reciprocal signaling between neurons and
astrocytes.
POTASSIUM HOMEOSTASIS
A correct K+ homeostasis is a crucial factor in the control of neu-
ronal excitability. Because even small elevations in the extracellular
K+ concentrations ([K+]o) can significantly increase neuronal
network activity, it was hypothesized that [K+]o is a causal fac-
tor for epileptiform activity. Indeed, perfusion of brain slices with
high K+ is effectively used to induce epileptic-like discharges in
neurons. Moreover, a bulk of experimental studies performed in
different in vitro and in vivo models of epilepsy showed that seizure
activity itself can lead to a significant extracellular K+ increase
up to 10–12 mM (Pedley et al., 1976; Heinemann et al., 1977,
1986; Lopantsev et al., 2009). A number of early studies also
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revealed a high and rapid permeability of glial cells to K+ ions,
even in response to small neuronal activities (Kuffler et al., 1966;
Orkand et al., 1966). In these initial studies the so-called “spa-
tial potassium buffering hypothesis” was advanced. According to
this hypothesis, astrocytes either singularly or connected through
gap-junctions, were proposed to redistribute local [K+]o increases
either to neighboring regions or directly into the blood vessels
(Orkand et al., 1966; Kofuji and Newman, 2004). Accordingly,
astrocytes are thought to play a predominant role in the clearance
of the K+ ions which accumulate in the extracellular space during
the intense neuronal firing that characterizes epileptic discharges.
Inward rectifying K+ channels (Kir) are the main responsible for
the high astrocytic K+ permeability. Of the 16 distinct Kir chan-
nel subunits which have been identified, type 4.1 (Kir4.1) and,
to a lesser extent, type 2.3 (Kir2.3) are the most intensively stud-
ied (Neusch et al., 2006; Olsen and Sontheimer, 2008). Notably,
astrocytes from different brain regions abundantly express Kir4.1
channels (Takumi et al., 1995; Ishii et al., 1997; Poopalasundaram
et al., 2000; Higashi et al., 2001; Li et al., 2001). Unlike other K+
channels that allow large K+ efflux from depolarized cells, such
as those that underline membrane repolarization during action
potential firing in neurons, Kir channels have the peculiarity to
mediate small K+ efflux from depolarized cells and large influx at
hyperpolarized potentials. Most importantly, due to a high open
probability at resting potential (Ransom and Sontheimer, 1995)
and a channel conductance that is proportional to [K+]o (Sak-
mann and Trube, 1984; Newman, 1993), Kir4.1 channels can be
effectively activated by large [K+]o increases and mediate a large
K+ influx.
Several studies showed altered Kir4.1 expression and activity in
epilepsy, both in humans and experimental animal models, as well
as in other disorders including brain injury. A reduction of astro-
cytic Kir4.1 channels expression was observed in several studies
on tissues from TLE patients (Bordey and Sontheimer, 1998; Hin-
terkeuser et al., 2000; Kivi et al., 2000; Schroder et al., 2000). Kir
currents recorded in astrocytes from human sclerotic hippocampi
were also reduced (Heinemann et al., 2000; Hinterkeuser et al.,
2000). It is, however, unclear whether these changes are a reac-
tion of the tissue to the epileptiform activities or whether they are
directly involved in the genesis of the disease. The use of trans-
genic animals helped to address this issue and results obtained
confirmed the importance of Kir channels during epileptogenesis.
In particular, Kir4.1 knock-out mice exhibited an impaired K+
homeostasis in the retina (Kofuji et al., 2000) and the brain stem
(Neusch et al., 2006), and showed stress-induced seizures (Dju-
kic et al., 2007). In a recent in vivo study in Kir4.1 conditional
knock-out mice, the central role of Kir4.1 channels in the [K+]o
regulation in the hippocampal region was also reported (Chever
et al., 2010). Another compelling, although indirect, evidence for
the Kir involvement in the generation of epileptiform activities
is the finding that mutations or polymorphisms of KCNJ10, the
gene encoding Kir4.1 subunits,have been associated with increased
seizure susceptibility and epileptic phenotypes in mice (Ferraro
et al., 2004; Inyushin et al., 2010). Humans KCNJ10 mutations
are also associated to seizure susceptibility, idiopathic generalized
epilepsy (Buono et al., 2004; Lenzen et al., 2005) or to complex
syndromes that encompass epilepsy (Bockenhauer et al., 2009;
Scholl et al., 2009; Reichold et al., 2010). Notably, a reduced
Kir4.1-mediated K+ buffering, due to conditional knock-out of
Kir4.1 channels or polymorphism of KCNJ10, has been linked to a
reduced glutamate clearance (Djukic et al., 2007; Kucheryavykh
et al., 2007; Inyushin et al., 2010) that further contributes to
increase network excitability. Altogether, these observations sup-
port the view that either a reduced Kir channel expression or a
functional impairment of these channels due to neuronal injury
or gene polymorphisms can increase network activity leading to a
higher susceptibility to proconvulsant stimuli or to generation of
a full epileptic activity. As crucial regulators of [K+] and network
excitability, astrocytic Kir channels represent potential targets for
a novel therapeutic approach for epilepsies.
WATER HOMEOSTASIS
Water homeostasis is another aspect of great importance in
brain pathophysiology in which astrocytes play a pivotal role.
Different conditions such as brain ischemia, injury, or hepatic
encephalopathy can result in cerebral edema that is mainly due
to water accumulation in astrocytes. Astrocyte swelling leads to
a reduction of the extracellular space that enhances network
excitability and favors epileptiform discharges (Dudek et al., 1990;
Andrew, 1991; Roper et al., 1992; Chebabo et al., 1995; Pan and
Stringer, 1996), possibly due to an increase of ephaptic interactions
between neurons. Astrocyte swelling can also result in an increased
release of gliotransmitters, such as glutamate, via volume-sensitive
organic anion channels (VSOACs), that further enhances network
excitability. Water influx in astrocytes is meditated by the water
channel aquaporin 4 (AQP4) that is, indeed, highly expressed in
these cells (reviewed by Badaut et al., 2002, 2007) with a prevalent
localization in perivascular endfeet (Nielsen et al., 1997; Higashi
et al., 2001; Nagelhus et al., 2004). The peculiar anchoring of AQP4
on perivascular endfeet seems to rely on α-syntrophin, a dys-
trophin complex protein (reviewed by Amiry-Moghaddam et al.,
2004) that is important to link intracellular water content to blood
circulation. Interestingly, AQP4 channels colocalize with Kir4.1
(Nagelhus et al., 2004) and AQP4 deficient or knock-out mice show
a slowed K+ influx. These latter mice also show prolonged seizures
(Amiry-Moghaddam et al., 2003; Binder and Steinhauser, 2006).
These and other studies support the hypothesis that AQP4 and
Kir4.1 channels cooperate in the regulation of water and K+ home-
ostasis in brain tissue. Like Kir4.1 channels, AQP4 are also altered
in the sclerotic human hippocampi with an overall increase of
expression (Lee et al., 2004), but a redistribution from the perivas-
cular site to the perisynaptic one (Lee et al., 2004). Similar results
are also observed in epileptic tissue with focal cortical dysplasia
(FCD), a cortical malformation that frequently generates epilep-
tic foci (Medici et al., 2011). In another recent study, a decreased
expression of AQP4 has been observed in the kainic acid model
of epileptogenesis in wild-type mice together with an increase of
seizures occurrence in AQP4−/−mice (Lee et al., 2012). An altered
distribution of AQP4 may thus reduce the transfer of water from
astrocytes into blood vessels. This would lead to astrocyte swelling,
reduced clearance of both extracellular K+ and glutamate as well
as an increase in glutamate release, also through volume-sensitive
anion channels, triggering a deleterious loop that can further facil-
itate cell swelling. A recent work has shown a critical role of AQP4
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also for astrocytic Ca2+ signaling (Thrane et al., 2011). In partic-
ular, the authors showed that hypo-osmotic stress triggers Ca2+
increases in astrocytes and this response depends on AQP4 and,
partially, on P2Y receptors. Consistent with an important role of
AQ-4 in astrocytic Ca2+ signaling and astrocyte-neuron interac-
tions, AQ-4 knock-out mice exhibited a cognitive defect and a
reduction of a distinct form of hippocampal LTP (Skucas et al.,
2011). Altogether, the currently available data suggest a strong
involvement of astrocytic water channels in epileptogenesis (for
review see Binder et al., 2012).
GLUTAMATE AND GABA
According to a classical paradigm epileptiform activities may arise
from a brain network that becomes hyperexcitable by an imbalance
in glutamatergic and inhibitory GABAergic transmission (Prince
and Wilder, 1967; Bradford, 1995). This simple view has been
recently revisited taking into account that GABAergic transmis-
sion may favor epileptic activity by synchronizing large neuronal
populations and even depolarize, at least under certain conditions,
the neuronal membrane thereby enhancing neuronal excitability
(Cossart et al., 2005; Fritschy, 2008; Avoli and de Curtis, 2011).
Although the ultimate action of GABAergic transmission may be
context-dependent, seizure threshold is strongly affected by the
dynamics of both glutamate and GABA signals. The tonic extracel-
lular level of these neurotransmitters can also contribute to control
network excitability. As regards glutamate, the large amount of this
neurotransmitter, released into the extracellular space by the activ-
ity of both glutamatergic synapses and astrocytes, is internalized
by an efficient reuptake system that includes five different excita-
tory amino acid transporters, EAAT1-5. EAAT1 and EAAT2 are
selectively expressed in astrocytes (GLAST and GLT-1 in rodents,
respectively) and they represent the main regulators of extracellu-
lar glutamate levels in the brain (Rothstein et al.,1994; Tanaka et al.,
1997). An additional factor that contributes to set the extracellular
glutamate concentration in the brain is the glutamate metabolism.
According to the glutamate-glutamine cycle, glutamate is mainly
synthesized in astrocytes starting from the glucose internalized by
astrocyte endfeet in contact with cerebral blood arterioles. Glucose
is then converted to glutamate (via α-ketoglutarate) and succes-
sively to glutamine by the specific astrocytic enzyme glutamine
synthetase (GS). Glutamine released from astrocytes is captured
by glutamatergic neurons through specific transporters and finally
deaminated to glutamate by phosphate activated glutaminase. In
astrocytes the extracellular glutamate is internalized and converted
again into glutamine that is then transferred to neurons to start a
new cycle.
High extracellular glutamate levels have been reported in
human epileptic tissues (During and Spencer, 1993; Glass and
Dragunow, 1995; Cavus et al., 2005). These observations lead to
the hypothesis that an increased glutamatergic transmission may
be an early event that contributes to the generation of distinct types
of epilepsy. Controversial results have been, however, reported in
studies investigating the EAAT levels from tissues of TLE patients
(reviewed by Eid et al., 2008b; Seifert et al., 2010). While some stud-
ies revealed a down regulation of astrocytic glutamate transporters
(Mathern et al., 1999; Proper et al., 2002; Sarac et al., 2009), others
failed to observe similar alterations (Tessler et al., 1999; Eid et al.,
2004). The potential of astrocytic EEAT transporters to participate
in seizure generation was, however, demonstrated in a transgenic
mouse line in which a deletion of EATT2 in astrocytes resulted
in epileptiform activities (Tanaka et al., 1997). In addition, in an
animal model of focal epilepsy induced by a blood brain barrier
(BBB) disruption that mimics post-traumatic epilepsy, a reduced
glutamate and K+ clearance capacity was reported (David et al.,
2009; see also below).
A more general consensus regards the loss of GS in the hip-
pocampus from TLE patients that showed elevated extracellular
glutamate levels (Eid et al., 2004; van der Hel et al., 2005). Reduced
GS levels and activity are thought to increase extracellular glu-
tamate levels because the intracellular conversion of glutamate
to glutamine favors the uptake of glutamate from extracellular
space (Otis and Jahr, 1998). It was recently shown that inhibi-
tion of GS by methionine sulfoximine induced recurrent seizures
in animal models (Eid et al., 2008a; Wang et al., 2009). Notably,
astrocytic glutamine is not only the main source of glutamate
in pyramidal neurons, but it also produces GABA in GABAergic
interneurons. Among the different interneurons, the fast-spiking
subtype demands a very efficient GABA recycling system due to the
very high frequency of action potential firing in these cells. Indeed,
the inhibition of astrocytic GS in experimental animal models
leads to reduced inhibitory synaptic currents and GABA release
without similar changes in the glutamatergic pathway (Liang et al.,
2006; Kam and Nicoll, 2007; Ortinski et al., 2010). Consistent
with this view, reduced levels and activity of GS in the epilep-
tic brain were observed to favor seizure generation by increasing
extracellular glutamate and decreasing GABA release at presynap-
tic terminals. Interestingly, in a recent study in different genetic
models of absence seizures – a form of thalamic epilepsy with
excessive GABA levels – a reduced GABA uptake in astrocytes was
found to be a causal factor for this epileptic phenotype, point-
ing out at an astrocytic dysfunction as a main cause also for this
type of epilepsy (Cope et al., 2009). Although some controversial
aspects need to be addressed, results from these studies support the
hypothesis that altered glutamate/GABA metabolism and uptake
in astrocytes can play an important role in the epileptic brain.
While the interactions between GABAergic interneurons and
astrocytes have been poorly addressed in the context of epilepsy,
it is noteworthy that astrocytes are also a source of neurosteroids,
a class of potent endogenous modulators of GABAA receptors
with sedative, anxiolytic, and anticonvulsive properties (Lambert
et al., 2003; Reddy, 2010). Neurosteroids such as allopregnanolone
(3α-hydroxy-5α-pregnane-20-one) and allotetrahydrodeoxycorti-
costerone (THDOC; 3α,21-dihydroxy-5α-pregnan-20-one), can
either originate in peripheral organs or be synthesized de novo
in the brain by both neurons and astrocytes (Mensah-Nyagan
et al., 1999; Agis-Balboa et al., 2006). Interestingly, the cytochrome
P450 cholesterol side-chain cleavage enzyme (P450scc) that cat-
alyzes the initial step of neurosteroid biosynthesis in the brain
was found to be increased in hippocampal astrocytes during the
latent period after pilocarpine-induced status epilepticus (SE) in
rats (Biagini et al., 2006, 2009). In these studies longer SE was
correlated to higher P450scc expression in astrocytes and longer
latent period, while blockade of neurosteroid synthesis accelerated
seizure onset, suggesting that activated astrocytes may temporarily
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prevent spontaneous seizure onset by producing neurosteroids.
These data raise the hypothesis of an anticonvulsant action of
astrocytes and press for additional studies aimed to clarify their
role in the production of neurosteroids and of other modulators
of neuronal excitability.
GLIOTRANSMISSION: GLUTAMATE RELEASE
The excessive brain network excitability and the hypersynchronous
discharges that are observed in epileptic disorders are believed to
represent abnormalities intrinsic to neurons. In the generation
of epileptiform activity non-neuronal mechanisms may, however,
also contribute (Konnerth et al., 1986; Dudek et al., 1998; Jefferys,
2003). Astrocytes can represent, indeed, an extrasynaptic source of
glutamate that triggers synchronized activities in groups of neu-
rons from different brain regions (Angulo et al., 2004; Fellin et al.,
2004, 2007). Paired patch-clamp recording experiments from two
pyramidal neurons revealed that the release of glutamate from
astrocytes – in response to Ca2+ elevations evoked by different
agents or direct mechanical stimulation – induced in both neu-
rons N -methyl-d-aspartic acid (NMDA) receptor-mediated slow
inward currents (SICs) that could occur with a high level of syn-
chrony (Angulo et al., 2004; Fellin et al., 2004). Ca2+ imaging
experiments also revealed that astrocyte Ca2+ elevations could be
followed by episodes of simultaneous Ca2+ elevations in small
groups of adjacent neurons, a response that we termed a “domain
response” (Fellin et al., 2004). It resulted that stimuli commonly
used to activate a Ca2+ signal in astrocytes, such as agonists of type
I metabotropic glutamate receptors (mGluRs), purinergic, and
prostaglandin E2 receptors, triggered in the presence of TTX gluta-
mate release from astrocytes and synchronous activity in neurons
(Fellin et al., 2004, 2006b). Given that the Ca2+ dependent release
of glutamate from astrocytes could promote local synchronous
activities in hippocampal neurons, it was reasonable to propose
that an excessive activation of Ca2+ elevations in astrocytes may
result in a massive glutamate release and represent a relevant non-
neuronal mechanism of hypersynchronous discharges in neurons.
In support of this view, studies performed both on brain slices
and in vivo showed that during epileptiform activity, the frequency
of Ca2+ oscillations in astrocytes is significantly increased (Tian
et al., 2005; Fellin et al., 2006a), while it is reduced by anticon-
vulsant drugs (Tian et al., 2005). Moreover, mGluR expression
in hippocampal astrocytes from animal models of temporal lobe
epilepsy was also found to be increased (Aronica et al., 2000;
Ulas et al., 2000). Furthermore, glutamate released from rodent
astrocytes during SE contributes to neuronal death (Ding et al.,
2007). This process could be averted by inhibiting glia-neuron
signaling and by applying mGluR5 and NR2B NMDA receptor
antagonists which suppress astrocytic Ca2+ increase and block
extrasynaptic NMDA receptors activated by glia-derived glutamate
(Ding et al., 2007). These observations support the hypothesis that
an increase excitability in the neuron–astrocyte network favors
neuronal synchronization and ultimately predisposes neurons to
seizures.
In five different experimental models of chemically induced
epilepsy, 70–90% of paroxysmal depolarizing shifts (PDSs), i.e.,
interictal spikes, were found to be insensitive to tetrodotoxin appli-
cations (Kang et al., 2005; Tian et al., 2005). Given that astrocytic
glutamate plays a prominent role in the generation of such a large
fraction of PDSs, SICs coincide, according to these authors, with
PDSs and seizure activity may have an astrocytic basis (Tian et al.,
2005). This conclusion, however, fueled a controversial debate on
the role of astrocytes in epileptogenesis since it contradicts a large
number of previous studies showing that TTX efficiently blocks
PDS (D’Ambrosio, 2006; Seifert et al., 2006; Wetherington et al.,
2008). The conclusion by Tian et al., was also disputed by subse-
quent studies which further confirmed the sensitivity of PDS to
TTX (Fellin and Haydon, 2005; Gomez-Gonzalo et al., 2010). On
the other hand, it is rather unlikely that astrocyte-mediated SICs
in pyramidal neurons represent PDSs. SICs have been demon-
strated to be mediated exclusively by NMDA receptors (Angulo
et al., 2004; Fellin et al., 2004; Perea and Araque, 2005), while PDSs
were reported to be, at least in large part, insensitive to D-AP5.
As reviewed by Wetherington et al. (2008) a huge amount of data
strongly support the conclusion that SICs and PDSs, in spite of a
similar time course, are distinct events and derive from a different
cellular source.
The results reported above do not rule out the possibility, how-
ever, that astrocytic glutamate is an important factor in epilepti-
form activities (Fellin et al., 2006a). A recent study from our group
helped to clarify the effective weight of the astrocyte contribution
to the generation of epileptic discharges (Gomez-Gonzalo et al.,
2010). We found that astrocytes could contribute to seizure-like
ictal discharge, but not to interictal discharge arising sponta-
neously in our picrotoxin/low Mg2+ cortical slice model. Indeed,
astrocyte Ca2+ elevations were observed to regularly accompany
the generation of the ictal discharge,but these events were observed
only rarely in a few astrocytes during the interictal discharges
(Figure 1). To further define the role of astrocytes in the gen-
eration of epileptiform activities, we also used additional models
of epileptic seizures, including a new model of stimulus-evoked
seizures (Losi et al., 2010). In the new model, an episode of hyper-
activity that is induced in a small group of neurons by local NMDA
applications in the presence of the proconvulsant 4-amino pyri-
dine (4-AP), generates an ictal, seizure-like discharge that from
this epileptogenic site propagates to adjacent neuronal popula-
tions. The unique advantage of the new model is that we know in
advance when and where a focal seizure will occur, giving us the
opportunity to investigate the earlier cellular events that develop
at the epileptogenic site during the preictal, transition phase, and
predispose neurons to seizures. We found that neuronal hyperac-
tivities at these restricted brain sites are accompanied by an early
Ca2+ elevation in a large number of astrocytes (see Figure 1)
that contributes to drive neurons toward the threshold of seizure
discharge generation (Gomez-Gonzalo et al., 2010). Indeed, the
onset of Ca2+ elevations in astrocytes from the epileptogenic site
occurred a few seconds before the initial development of focal,
seizure-like discharges. Most importantly, we were able to show
that the early astrocyte activation was not a mere consequence
of the episode of high neuronal activity triggered by NMDA and
it rather represents a crucial step in the generation of the ictal
discharge. After the Ca2+ chelator BAPTA was introduced into
the astrocyte syncytium by patching individual astrocytes with a
BAPTA-containing pipette, the Ca2+ elevations in astrocytes were
strongly reduced and the NMDA stimulation that was normally
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FIGURE 1 | Astrocytes are activated during focal seizure propagation in
cortical slices. (A) Image sequence of the fluorescence signal change in
layer V–VI neurons (n, black arrows) and astrocytes (a, yellow arrowheads)
from the entorhinal cortex of a young rat after slice loading with the Ca2+
dye Oregon-Green BAPTA1-AM during a propagating ictal discharge. (B)
Simultaneous patch-clamp recording from one neuron [black trace; the
patch-pipette is indicated in (A)] and ∆F /F 0 traces of the Ca2+ signal in the
same neuron (superimposed red trace) and other neighboring neurons (red
traces) and astrocytes (blue traces). The Ca2+ signal from all neurons
precisely matched the electrical activity of the patched neuron during both
the interictal event (single event at trace onset) and the subsequent ictal
discharge. Astrocytes were strongly activated during the ictal discharge
while they were poorly activated by the interictal discharge (adapted from
Gomez-Gonzalo et al., 2010).
successful failed to evoke an ictal discharge. According to results
obtained from different control experiments, the effect of BAPTA
on ictal discharge generation was specifically linked to the inhibi-
tion of astrocyte Ca2+ signals, and, possibly, to the inhibition of
gliotransmitter release, such as glutamate and d-serine, that can
favor synchronous neuronal activities.
These results suggest that when an episode of hyperactivity
in a group of neurons consistently engages nearby astrocytes, a
feedback signal from these latter cells enlarges the population of
neurons recruited into a coherent activity. If this signal operates on
a brain network prone to seizures, neurons are driven toward the
ictal discharge threshold. It is worthwhile to emphasize here that
when the astrocyte contribution was reduced, for example fol-
lowing BAPTA intracellular applications, the ictal discharge was
inhibited, but it could be recovered by applying a higher NMDA
stimulation (Gomez-Gonzalo et al., 2010). By activating directly
a larger number of neurons, this higher stimulus evokes a level of
correlated activity that is sufficient for seizure-like discharge gen-
eration, bypassing the astrocyte contribution in the recruitment
process. Thus, astrocytes are not an absolute requirement, but they
can provide an important and even, under certain circumstances,
crucial contribution to ID generation.
GLIOTRANSMISSION: ATP RELEASE
Another gliotransmitter that plays a relevant role in the con-
trol of epileptic activity is ATP. The effect of ATP can be even
more complex than that of glutamate and exert in the neuronal
network both pro and anticonvulsant actions. ATP is released
from astrocytes either through a Ca2+-dependent (Coco et al.,
2003; Pascual et al., 2005) or a Ca2+-independent mechanism,
the latter involving connexin and pannexin hemichannels (for a
review, see Burnstock et al., 2011). Astrocytic ATP and its main
metabolite adenosine (Ado) exert a plethora of actions on astro-
cytes, neurons, microglia, oligodendrocytes, and blood vessels
through different purinergic receptors. ATP is responsible for
the slow Ca2+ waves that propagate across the astrocytic syn-
cytium by acting on P2Y receptors (Cotrina et al., 1998; Koizumi,
2010).
While ATP can directly excite neurons through P2 receptors
with pro-epileptic effects (for a review, see Kumaria et al., 2008), it
might also have an anticonvulsant action due to activation of P2Y
receptors on inhibitory interneurons (see below) or for the effects
of its metabolite Ado. This strongly inhibits excitatory neurotrans-
mitter release through activation of presynaptic A1 receptors and
is considered, indeed, a potent endogenous anticonvulsant (for
reviews see Li et al., 2007; Boison, 2008, 2010). Ado derived from
astrocytic ATP is also at the basis of some distinct forms of synaptic
plasticity such as the heterosynaptic depression in the hippocam-
pus (Zhang et al., 2003, p. 6691; Pascual et al., 2005, p. 7468;
Serrano et al., 2006, p. 8330). In light of these findings astro-
cytic ATP may initially favor (via P2 receptors) and then inhibit
epileptic activity after its conversion to Ado (via A1 receptors).
Noteworthy is also that astrocytes are major regulators of extra-
cellular Ado levels since these cells are not only its major source
but they also predominantly express adenosine kinase (ADK), an
enzyme that efficiently degrades Ado (Gouder et al., 2004; Boison,
2005). In the epileptic brain, including the hippocampus from
patients with temporal lobe epilepsy, ADK is increased resulting
in decreased extracellular Ado concentrations that favor network
excitability (Gouder et al., 2004; Aronica et al., 2011). Notably, cell
grafts releasing Ado and genetic reduction of ADK were shown to
prevent seizures and reduce epileptogenesis in animal models of
epilepsy (Huber et al., 2001; Li et al., 2007, 2008). These obser-
vations suggest that ADK can be considered not only a diagnostic
marker of epilepsies,but also a potential target for the development
of a new therapy that could prevent epileptic seizures (Boison,
2008; Theofilas et al., 2011).
Interestingly, a recent study showed that a local Ca2+ decrease
in the extracellular space initiates a Ca2+ wave in astrocytes
Frontiers in Pharmacology | Neuropharmacology July 2012 | Volume 3 | Article 132 | 6
Losi et al. Atsrocytes in epilepsy
specifically mediated by astrocytic ATP release through connexin
43 hemichannels (Torres et al., 2012). This astrocytic ATP
enhances inhibitory transmission by acting on the P2Y1 recep-
tors expressed in a subset of hippocampal interneurons (Torres
et al., 2012). Given that during epileptic activity the extracellular
Ca2+ is markedly reduced, the consequent release of astrocytic
ATP could potentiate inhibitory transmission thereby working
as an anticonvulsant feedback mechanism that opposes seizure
propagation.
All in all, it can be predicted that ATP gliotransmission may
soon be recognized as target for developing new antiepileptic
therapies.
INFLAMMATION
A large variety of brain insults including stroke, acute infections,
trauma, febrile seizures, and cancer are associated with a high
risk of developing epilepsy and all these conditions are known
to trigger a rapid inflammatory reaction in the brain tissue. The
FIGURE 2 | Schematic of the main astrocyte actions that can
affect epileptiform activities.The colored circles mark the
anticonvulsant (green) and the proconvulsant (red) actions of
astrocytes. Note that (i) ATP can have per se a proconvulsant action,
but after its conversion to Ado it is anticonvulsant; (ii) astrocytic
cytokines can have either pro- or anti-inflammatory actions. ADK,
adenosine kinase; Ado, adenosine; AQP4, aquaporin 4; BBB, blood
brain barrier; Cx43, connexin 43; EAAT, excitatory amino acid
transporters; EN, ectonucleotidase; ER, endoplasmatic reticulum;
GAT, GABA transporters; glu, glucose; glut, glutamate; gln, glutamine;
GS, glutamine syntethase; NS, neurosteroids; VSOACs,
volume-sensitive organic anion channels.
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activation of inflammatory pathways appears, indeed, to play an
important role in the etiopathogenesis of several forms of epilepsy
(Turrin and Rivest, 2004; Vezzani and Granata, 2005; Vezzani
et al., 2008; Fabene et al., 2010). Among the inflammatory agents
that are highly expressed in the epileptogenic tissue are the pro-
inflammatory cytokines IL-1β and TNFα . Main sources of these
cytokines are microglia and astrocytes. The mechanism at the basis
of the IL-1β proconvulsant action is not completely understood.
Recent works suggest that IL-1β acts on neuronal IL-1β receptor 1
(IL-1R1), the IL-1R accessory protein, myeloid differentiation pri-
mary response protein complex (MyD88) and Src family kinases
to ultimately enhance NMDA-mediated Ca2+ influx by increasing
the phosphorylation of the NR2B subunit (Viviani et al., 2003;
Balosso et al., 2008). Other mechanisms are, however, possible. In
a recent study in brain slices IL-1β was reported to induce hyper-
excitability independently of NMDA receptors (Rossi et al., 2012).
The authors report an increased occurrence of AMPA receptor-
mediated spontaneous excitatory synaptic currents due to the
action of IL-1βon transient receptor potential vanilloid 1 (TRPV1)
channels.
It is worth underlying that IL-1β and TNFα were also reported
to act on astrocytes, significantly reducing glutamate uptake and
increasing glutamate release in these cells (Ye and Sontheimer,
1996; Hu et al., 2000; Bezzi et al., 2001; Santello et al., 2011) raising
the possibility that the proconvulsant action of these cytokines can
be linked, at least in part, to a direct effect on astrocytes. In a series
of recent work it was also shown that in neocortex the disruption
of the BBB, an event frequently associated with neuroinflamma-
tion, leads to a rapid astrocyte activation with increased GFAP
expression. This is due to albumin diffusion which is selectively
captured by astrocytes through a mechanism involving TGF-β
receptors. Indeed, an increased BBB permeability is proposed to
contribute to the generation of an epileptogenic focus (Seiffert
et al., 2004; Ivens et al., 2007; Tomkins et al., 2007; Friedman et al.,
2009). Importantly, the rapid gliosis that follows a disruption of
the BBB was associated with a reduced expression of Kir channels,
gap-junctional proteins, and glutamate transporters in astrocytes
that lead to an increased network excitability by reducing K+ and
glutamate uptake (David et al., 2009).
The high-mobility group box-1 (HMGB1) is an additional
inflammatory agent (Müller et al., 2004; Pedrazzi et al., 2007; Sims
et al., 2010) recently revealed to be involved in seizure generation
(Maroso et al., 2010). HMGB1 is produced by both neurons and
glia and its action appears to be mediated by the toll-like receptor
4 (TLR4), a receptor that recognizes several pathogenic microbial
molecules (Maroso et al., 2010).
Although many molecular aspects remain to be elucidated,
these studies provide significant support to the hypothesis that
astrocytes are directly involved in the inflammatory reaction that
favor the development of epilepsy.
CONCLUSIONS AND PERSPECTIVES
Astrocytes are key players in the regulation of brain tissue home-
ostasis and neuronal excitability. A large body of evidence showed
the impairment of several astrocytic functions in the epileptic
brain, such as the control of water and ionic equilibrium, neu-
rotransmitter concentrations, cerebral blood flow, and the ability
to release modulators and cytokines. Although a dysregulation of
a number of astrocyte-specific functions has been identified and
linked to epilepsies, the precise role of gliotransmission in initia-
tion and propagation of seizures is unclear and many key questions
remain unanswered. Among these questions it is relevant to clarify
if and under which conditions the different gliotransmitters exert
a pro or an anticonvulsant action (see Figure 2). Very likely, the
signaling of astrocytes to principal neurons and distinct interneu-
rons through glutamate release may be context-dependent and
needs selective tools to be elucidated. ATP-mediated gliotrans-
mission is another promising field for future experiments given
its role in mediating Ca2+ waves in the astrocytic syncytium and
its wide effects on neuronal functions. Accordingly, a clarification
of ATP release mechanisms could potentially allow the develop-
ment of selective tools to modulate gliotransmission and network
excitability. As to epileptogenesis, an important issue is whether
astrocytes favor the generation of epileptic events or may, instead,
oppose it by releasing, for example, molecules like neurosteroids
and trophic factors. To address these questions a great help is pro-
vided by new experimental approaches that use molecular genetic
tools to selectively affect specific signaling pathways in astrocytes
as well as by the application of Ca2+ imaging techniques in in vivo
animal models of epilepsy.
Clarification of the astrocyte role in brain disorders represents
one of the most difficult, but also one of the most fascinating
challenges in neurobiological research in the years to come.
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